Today’s Stock Market in 2-Minutes
September 1, 2026
-
-
Syra Health, Wake County Public Health Expand Wellness Partnership
September 1, 2026
-
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
September 1, 2026
-
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
September 1, 2026
-
Top News
- Bimergen Energy to Present Their $400 Million Growth Strategy at the Moody Capital Solutions 2026 Conference September 1, 2026
- Auddia Announces Influence Healthcare’s First Specialty Hospital LOI, Marking a Major Milestone in the Company’s Healthcare Expansion September 1, 2026
- AEye’s Apollo(TM) Lidar Selected by Lunar Outpost for Pegasus Lunar Terrain Vehicle, Opening a New Market Category in Space Mobility September 1, 2026
- NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces Distributions September 1, 2026
Axe Compute (NASDAQ AGPU) 2026 Q2 Earnings Call
Watch the replay of Axe Compute's Second Quarter 2026 earnings conference call, originally held live on Monday, August 17, 2026 at 8:30 a.m. Eastern Time. Christopher Miglino, Chief Executive Officer; Kyle Okamoto, President; and Jeremy Yaukey-Witter, Chief Financial Officer, review the Company's Q2 2026 financial results, recent business developments, and priorities for the second half of 2026. Key highlights discussed on the call: Revenue grew more than 90x sequentially in the Company's first full quarter of compute operations Customer prepayments grew from $0.8 million to $60.8 million, with $17.4 million in operating cash flow in the first half of 2026 The $260 million dedicated cluster of 2,304 NVIDIA B300 GPUs progressed through build, targeted for Q3 2026 go-live Total 2026 signed contracted value now exceeds $3 billion Read the full press release and financial statements on Axe Compute's investor website.
August 17, 2026Popular Reads
-
Verde and Highway International Sign Strategic Memorandum of Understanding to Advance Carbon-Sequestering Roads in Singapore
ST. LOUIS and SINGAPORE, Aug. 31, 2026 (GLOBE NEWSWIRE) — Verde Resources Inc. (OTCQB: VRDR) (“Verde”) today announced that its wholly owned Singapore subsidiary, Verde Resources Asia Pacific Private Limited, has entered into a strategic Memorandum of Understanding (“MoU”) with Highway International Private Limited (“Highway”), one of the leading asphalt producers and road construction specialists in Singapore. […]
August 31, 2026
-
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant’s Allogeneic Growth Factor into the Dental Market
Partnership leverages BioHorizons’ commercial network to broaden availability of Xtant’s allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand as Prolifica™ BELGRADE, Mont., Aug. 27, 2026 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, announced an […]
August 27, 2026
-
Lightbridge Selected for U.S. Department of Energy Launch Pad INL Program to Advance Commercialization of Lightbridge Fuel(TM)
Provides an Accelerated Pathway toward DOE Authorization to Manufacture Lead Test Assemblies of Lightbridge Fuel for Operation in Commercial Power Reactors RESTON, Va., Aug. 31, 2026 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that it has been selected to participate in the Nuclear Energy Launch […]
August 31, 2026
-
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
ARLINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) — Kala Bio, Inc. (Nasdaq: KALA) (“Kala”) and Virotek Inc. (“Virotek”), a CLIA-registered precision health and clinical genomics company, today announced that they have entered into a letter of intent (the “LOI”) outlining the principal terms under which the companies intend to negotiate a definitive agreement appointing Kala as the […]
September 1, 2026
News
-
Today’s Stock Market in 2-Minutes
September 1, 2026
-
LiqTech Expands Aquatics Partnership with Pool4You to Strengthen QlariFlow(TM) Presence in Finland
September 1, 2026
-
Expensify Launches Native Integration with Rillet, the AI-Native ERP
September 1, 2026
-
Syra Health, Wake County Public Health Expand Wellness Partnership
September 1, 2026
-
Fobi AI Launches AgenticBrain, Bringing Conversational Agentic AI to the Fobi Flywheel
September 1, 2026
-
NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces Distributions
September 1, 2026
-
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
September 1, 2026
-
AEye’s Apollo(TM) Lidar Selected by Lunar Outpost for Pegasus Lunar Terrain Vehicle, Opening a New Market Category in Space Mobility
September 1, 2026